SAGE Therapeutics IncNASDAQ:SAGE
- LAST PRICE11.5000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots11.1000/ 1
- Ask / Lots11.7300/ 1
- Open / Previous Close0.0000 / 11.5000
- Day Range---
- 52 Week Range
- Volume238
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | SAGE |
|---|---|---|
| 09:32 ET | 12300 | 10.88 |
| 09:34 ET | 1209 | 10.94 |
| 09:36 ET | 5703 | 11.01 |
| 09:38 ET | 600 | 10.96 |
| 09:39 ET | 4516 | 11.01 |
| 09:41 ET | 49757 | 11.02 |
| 09:43 ET | 113 | 11.03 |
| 09:45 ET | 2251 | 11 |
| 09:48 ET | 3947 | 10.955 |
| 09:50 ET | 1109 | 10.89 |
| 09:52 ET | 1368 | 10.94 |
| 09:54 ET | 1099 | 10.9113 |
| 09:57 ET | 1376 | 10.95 |
| 09:59 ET | 1827 | 10.95 |
| 10:01 ET | 3588 | 10.88 |
| 10:03 ET | 3618 | 10.9299 |
| 10:06 ET | 1306 | 10.96 |
| 10:08 ET | 560 | 10.97 |
| 10:10 ET | 2744 | 10.93 |
| 10:12 ET | 516 | 10.94 |
| 10:14 ET | 2654 | 10.9403 |
| 10:15 ET | 3702 | 10.95 |
| 10:17 ET | 8044 | 11.06 |
| 10:19 ET | 18012 | 11.16 |
| 10:21 ET | 9350 | 11.115 |
| 10:24 ET | 5244 | 11.14 |
| 10:26 ET | 31435 | 11.2199 |
| 10:28 ET | 1695 | 11.255 |
| 10:30 ET | 4920 | 11.32 |
| 10:32 ET | 10880 | 11.38 |
| 10:33 ET | 2220 | 11.382 |
| 10:35 ET | 14703 | 11.4786 |
| 10:37 ET | 6296 | 11.435 |
| 10:39 ET | 8626 | 11.47 |
| 10:42 ET | 1468 | 11.465 |
| 10:44 ET | 2421 | 11.415 |
| 10:46 ET | 2226 | 11.45 |
| 10:48 ET | 12081 | 11.395 |
| 10:50 ET | 6923 | 11.49 |
| 10:51 ET | 8545 | 11.48 |
| 10:53 ET | 895 | 11.48 |
| 10:55 ET | 1200 | 11.44 |
| 10:57 ET | 6336 | 11.405 |
| 11:00 ET | 3796 | 11.4 |
| 11:02 ET | 3642 | 11.45 |
| 11:04 ET | 500 | 11.455 |
| 11:06 ET | 500 | 11.47 |
| 11:08 ET | 1800 | 11.44 |
| 11:09 ET | 890 | 11.485 |
| 11:11 ET | 8719 | 11.5 |
| 11:13 ET | 1900 | 11.49 |
| 11:15 ET | 2000 | 11.49 |
| 11:18 ET | 1803 | 11.49 |
| 11:20 ET | 3791 | 11.48 |
| 11:22 ET | 3573 | 11.43 |
| 11:24 ET | 2973 | 11.455 |
| 11:26 ET | 500 | 11.45 |
| 11:27 ET | 211 | 11.45 |
| 11:29 ET | 2200 | 11.465 |
| 11:31 ET | 3926 | 11.495 |
| 11:33 ET | 568 | 11.51 |
| 11:36 ET | 14742 | 11.425 |
| 11:38 ET | 2184 | 11.3236 |
| 11:40 ET | 1291 | 11.29 |
| 11:42 ET | 1104 | 11.32 |
| 11:44 ET | 2558 | 11.34 |
| 11:45 ET | 2925 | 11.28 |
| 11:47 ET | 410 | 11.25 |
| 11:54 ET | 1620 | 11.22 |
| 11:56 ET | 768 | 11.21 |
| 11:58 ET | 2305 | 11.15 |
| 12:00 ET | 1938 | 11.16 |
| 12:02 ET | 100 | 11.15 |
| 12:03 ET | 268 | 11.16 |
| 12:05 ET | 2100 | 11.155 |
| 12:07 ET | 1939 | 11.16 |
| 12:09 ET | 1190 | 11.165 |
| 12:12 ET | 11814 | 11.19 |
| 12:14 ET | 923 | 11.215 |
| 12:16 ET | 600 | 11.215 |
| 12:18 ET | 1893 | 11.26 |
| 12:20 ET | 12309 | 11.39 |
| 12:21 ET | 6378 | 11.49 |
| 12:23 ET | 960 | 11.49 |
| 12:25 ET | 12403 | 11.445 |
| 12:27 ET | 1062 | 11.4 |
| 12:30 ET | 310 | 11.395 |
| 12:32 ET | 1616 | 11.34 |
| 12:34 ET | 5139 | 11.38 |
| 12:36 ET | 362 | 11.375 |
| 12:38 ET | 3742 | 11.37 |
| 12:39 ET | 976 | 11.355 |
| 12:41 ET | 2120 | 11.35 |
| 12:43 ET | 1994 | 11.38 |
| 12:45 ET | 600 | 11.4 |
| 12:48 ET | 1160 | 11.43 |
| 12:50 ET | 1100 | 11.445 |
| 12:52 ET | 4790 | 11.5 |
| 12:54 ET | 4915 | 11.41 |
| 12:56 ET | 722 | 11.41 |
| 12:57 ET | 32133 | 11.345 |
| 12:59 ET | 3443 | 11.33 |
| 01:01 ET | 600 | 11.27 |
| 01:03 ET | 4432 | 11.29 |
| 01:06 ET | 4468 | 11.305 |
| 01:08 ET | 500 | 11.305 |
| 01:10 ET | 2695 | 11.245 |
| 01:12 ET | 600 | 11.245 |
| 01:14 ET | 500 | 11.25 |
| 01:15 ET | 354 | 11.25 |
| 01:17 ET | 3304 | 11.2 |
| 01:19 ET | 2986 | 11.2 |
| 01:21 ET | 1200 | 11.2 |
| 01:24 ET | 9321 | 11.255 |
| 01:26 ET | 3617 | 11.2 |
| 01:28 ET | 3704 | 11.22 |
| 01:30 ET | 2766 | 11.24 |
| 01:32 ET | 5326 | 11.225 |
| 01:33 ET | 200 | 11.225 |
| 01:35 ET | 7572 | 11.25 |
| 01:37 ET | 3134 | 11.26 |
| 01:39 ET | 100 | 11.27 |
| 01:42 ET | 2023 | 11.32 |
| 01:44 ET | 2588 | 11.335 |
| 01:46 ET | 3019 | 11.35 |
| 01:48 ET | 300 | 11.37 |
| 01:50 ET | 1494 | 11.39 |
| 01:51 ET | 2043 | 11.35 |
| 01:53 ET | 2056 | 11.35 |
| 01:55 ET | 1268 | 11.355 |
| 01:57 ET | 1513 | 11.36 |
| 02:00 ET | 1894 | 11.38 |
| 02:02 ET | 2422 | 11.39 |
| 02:04 ET | 300 | 11.38 |
| 02:06 ET | 1748 | 11.365 |
| 02:08 ET | 700 | 11.35 |
| 02:09 ET | 357 | 11.36 |
| 02:11 ET | 2919 | 11.37 |
| 02:13 ET | 500 | 11.36 |
| 02:15 ET | 2530 | 11.375 |
| 02:18 ET | 3443 | 11.45 |
| 02:20 ET | 4381 | 11.47 |
| 02:22 ET | 9729 | 11.47 |
| 02:24 ET | 2838 | 11.46 |
| 02:26 ET | 335 | 11.45 |
| 02:27 ET | 2934 | 11.46 |
| 02:29 ET | 3519 | 11.47 |
| 02:31 ET | 1001 | 11.48 |
| 02:33 ET | 1074 | 11.495 |
| 02:36 ET | 1411 | 11.5 |
| 02:38 ET | 13211 | 11.56 |
| 02:40 ET | 2792 | 11.52 |
| 02:42 ET | 1407 | 11.535 |
| 02:44 ET | 3640 | 11.56 |
| 02:45 ET | 2826 | 11.6 |
| 02:47 ET | 2988 | 11.61 |
| 02:49 ET | 3221 | 11.59 |
| 02:51 ET | 4015 | 11.6 |
| 02:54 ET | 6079 | 11.56 |
| 02:56 ET | 4494 | 11.6 |
| 02:58 ET | 601 | 11.595 |
| 03:00 ET | 7328 | 11.632 |
| 03:02 ET | 3360 | 11.61 |
| 03:03 ET | 1786 | 11.6 |
| 03:05 ET | 4541 | 11.54 |
| 03:07 ET | 2086 | 11.53 |
| 03:09 ET | 1568 | 11.56 |
| 03:12 ET | 3652 | 11.5301 |
| 03:14 ET | 2956 | 11.5 |
| 03:16 ET | 4559 | 11.4888 |
| 03:18 ET | 2175 | 11.51 |
| 03:20 ET | 1567 | 11.53 |
| 03:21 ET | 6385 | 11.51 |
| 03:23 ET | 3272 | 11.51 |
| 03:25 ET | 2090 | 11.5 |
| 03:27 ET | 3156 | 11.49 |
| 03:30 ET | 1207 | 11.5 |
| 03:32 ET | 4003 | 11.505 |
| 03:34 ET | 2276 | 11.48 |
| 03:36 ET | 6354 | 11.505 |
| 03:38 ET | 1827 | 11.5075 |
| 03:39 ET | 2515 | 11.535 |
| 03:41 ET | 5875 | 11.56 |
| 03:43 ET | 4670 | 11.534 |
| 03:45 ET | 6352 | 11.525 |
| 03:48 ET | 10325 | 11.53 |
| 03:50 ET | 8957 | 11.57 |
| 03:52 ET | 13410 | 11.545 |
| 03:54 ET | 8997 | 11.495 |
| 03:56 ET | 25169 | 11.4901 |
| 03:57 ET | 18764 | 11.5 |
| 03:59 ET | 69807 | 11.5 |
Jun 12, 2024
DJ Sage Therapeutics Price Target Maintained With a $25.00/Share by HC Wainwright & Co., from 7:08AM ET on Wednesday Jun 12, 2024 by Dow Jones
7:08AM ET on Wednesday Jun 12, 2024 by Dow Jones
Jun 11, 2024
Allegations Against Sage Therapeutics, Inc.: Schall Law Firm Initiates Probe And Encourages Impacted Investors To Reach Out, from 7:45PM ET on Tuesday Jun 11, 2024 by Dow Jones
7:45PM ET on Tuesday Jun 11, 2024 by Dow JonesDJ Sage Therapeutics Is Maintained at Neutral by Baird, from 8:50AM ET on Tuesday Jun 11, 2024 by Dow Jones
8:50AM ET on Tuesday Jun 11, 2024 by Dow JonesSage Therapeutics Announces Phase 2 SURVEYOR Study Reinforces Cognitive Impact of Huntington's Disease, from 6:30AM ET on Tuesday Jun 11, 2024 by Dow Jones
6:30AM ET on Tuesday Jun 11, 2024 by Dow Jones
Jun 9, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
SAGE Therapeutics Inc | 653.0M | -1.4x | --- |
Regenxbio Inc | 647.7M | -2.2x | --- |
Zymeworks Inc | 661.8M | -5.1x | --- |
Y-mAbs Therapeutics Inc | 527.5M | -24.3x | --- |
Editas Medicine Inc | 496.7M | -2.6x | --- |
Urogen Pharma Ltd | 459.6M | -5.2x | --- |
Company Information
Sage Therapeutics, Inc. is a biopharmaceutical company. The Company has developed the two FDA-approved treatments indicated for postpartum depression and is advancing a robust pipeline to target unmet needs in brain health. The Company is targeting diseases and disorders of the brain across its clinical development and earlier stage pipeline. Its product ZURZUVAE is for the treatment of postpartum depression (PPD) in adults. ZURZUVAE is a neuroactive steroid that is a positive allosteric modulator of GABA receptors, targeting both synaptic and extra synaptic GABA receptors. Its product ZULRESSO (brexanolone) CIV injection is for the treatment of PPD in individuals 15 years old and older. It is also developing a portfolio of other novel compounds that target GABA receptors, including SAGE-324, which is a novel GABAA receptor positive allosteric modulator intended for chronic oral dosing. Its second area of focus for development is novel compounds that target the NMDA receptor.
Contact Information
- Headquarters
- 215 1st StCAMBRIDGE, MA, United States 02142-1213
- Phone
- 617-299-8380
- Fax
- 617-299-8379
Executives
- Independent Chairman of the Board
- Geno Germano
- President, Chief Executive Officer, Director
- Barry Greene
- Chief Financial Officer, Treasurer
- Kimi Iguchi
- Senior Vice President, General Counsel, Corporate Secretary
- Anne Cook
- Chief Business Officer
- Christopher Benecchi
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $653.0M |
|---|---|
Revenue (TTM) | $91.1M |
Shares Outstanding | 60.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.90 |
EPS | $-8.40 |
Book Value | $13.32 |
P/E Ratio | -1.4x |
Price/Sales (TTM) | 7.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -595.25% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
